Old Web
English
Sign In
Acemap
>
Paper
>
Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL
Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL
2021
Edd C Ricker
Brian Estrella
Manuel A Pazos
Jennifer E. Amengual
Keywords:
dual targeting
EZH2
Belinostat
Cancer research
Immunogenicity
Tazemetostat
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]